Relmada Therapeutics, Inc. (RLMD)
NASDAQ·Healthcare·Biotechnology
$5.50
+4.15%
Mkt Cap $556.97M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
Implied Upside
+100.0%
Consensus $11.00 vs current $5.50
NASDAQ·Healthcare·Biotechnology
$5.50
+4.15%
Mkt Cap $556.97M
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$11.00
Range $10.00 – $12.00
+100.0%
Consensus $11.00 vs current $5.50